Abstract:The intestine harbors a large population of microorganisms that interact with epithelial cells to maintain host healthy physiological status. These intestinal microbiota engage in the fermentation of non-digestible nutrients and produce beneficial metabolites to regulate host homeostasis, metabolism, and immune response. The disruption of microbiota, known as dysbiosis, has been implicated in many intestinal diseases, including colorectal cancer (CRC). As the third most common cancer and the second leading cause of cancer-related death worldwide, CRC poses a significant health burden. There is an urgent need for novel interventions to reduce CRC incidence and improve clinical outcomes. Modulating the intestinal microbiota has emerged as a promising approach for CRC prevention and treatment. Current research efforts in CRC probiotics primarily focus on reducing the incidence of CRC, alleviating treatment-related side effects, and potentiating the efficacy of anticancer therapy, which is the key to successful translation to clinical practice. This paper aims to review the traditional probiotics and new interventions, such as next-generation probiotics and postbiotics, in the context of CRC. The underlying mechanisms of probiotic anti-cancer effects are also discussed, including the restoration of microbial composition, reinforcement of gut barrier integrity, induction of cancer cell apoptosis, inactivation of carcinogens, and modulation of host immune response. This paper further evaluates the novel strategy of probiotics as an adjuvant therapy in boosting the efficacy of chemotherapy and immunotherapy. Despite all the promising findings presented in studies, the evaluation of potential risks, optimization of delivery methods, and consideration of intra-patient variability of gut microbial baseline must be thoroughly interpreted before bench-to-bedside translation.

Therapeutic approaches to colorectal cancer via strategies based on modulation of gut microbiota

Gut microbiota modulation: a tool for the management of colorectal cancer

Gut microbiome in tumorigenesis and therapy of colorectal cancer

Gut microbiota and colorectal cancer: insights into pathogenesis for novel therapeutic strategies

Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer

Strategies for the treatment of colorectal cancer caused by gut microbiota

Role of Gut Microbiota in the Development and Treatment of Colorectal Cancer

Microbe-based management for colorectal cancer

Interaction of gut microbiota with the tumor microenvironment: A new strategy for antitumor treatment and traditional Chinese medicine in colorectal cancer

Does the Microbiota Composition Influence the Efficacy of Colorectal Cancer Immunotherapy?

Intestinal microbiota: a novel perspective in colorectal cancer biotherapeutics

Beneficial insights into postbiotics against colorectal cancer

Exploring the Modulatory Effects of Gut Microbiota in Anti-Cancer Therapy

Correlation of Pathogenesis, Early Diagnosis and Treatment of Colorectal Cancer with Microorganisms

Probiotics intervention in colorectal cancer: From traditional approaches to novel strategies

Postbiotics in colorectal cancer: intervention mechanisms and perspectives

Gut microbiota in colorectal cancer development and therapy

Gut microbiota: An emerging therapeutic approach of herbal medicine for prevention of colorectal cancer

Gut Microbiota Impacts on the Efficacy of Anticancer Treatment of Colorectal Cancer

Gut microbiota in colorectal cancer: mechanisms of action and clinical applications

Colorectal cancer and gut microbiota studies in China